Skip to main content
Erschienen in: Journal of Neurology 2/2013

01.02.2013 | Original Communication

Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson’s disease

verfasst von: Juyeon Kim, Mijin Kim, Do Young Kwon, Woo-Keun Seo, Ji Hyun Kim, Jong Sam Baik, Seong-Beom Koh

Erschienen in: Journal of Neurology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Impulse control and repetitive behavior disorders (ICRBs) are a group of diseases including impulse control disorder (ICD), repetitive behavior disorder (RB), and dopamine dysregulation syndrome (DDS). This study determined the prevalence and associated characteristics of ICRBs in Parkinson’s disease (PD) patients. Included were 297 patients, interviewed with the questionnaire for impulsive-compulsive disorders in PD for screening of various ICRBs. Questionnaire results and clinical characteristics were analyzed. The ICRB prevalence among PD patients was 15.5 % (46 of 297), with 35 patients with ICD, 20 with RB, and 7 with DDS. Patients with ICRB were predominantly male, younger, taking higher doses of dopaminergic drugs, and had longer disease duration, worse Unified Parkinson’s Disease Rating Scale (UPDRS) motor score, and worse PD quality of life questionnaire score. However, each ICRB subtype had different risk factor profiles. ICD patients were predominantly male, younger, had longer disease duration, were affected by PD from young age, were taking higher total dopaminergic drug dosages, and had more RB. RB patients had higher UPDRS part III scores, were taking higher levodopa doses, and had higher comorbid ICD. DDS patients were taking higher dopamine agonist doses, and had more frequent ICD. In multivariate logistic regression for secondary analysis, only younger age and comorbid RB or DDS showed significant association with ICD and only poor UPDRS III score and comorbid ICD were significantly associated with RB. These findings suggested that different risk factors contribute to development of each ICRB subtype. ICRB could be a combination of heterogeneous disease entities that need to be treated separately.
Literatur
1.
Zurück zum Zitat Hoehn MM (1992) The natural history of Parkinson’s disease in the pre-levodopa and post-levodopa eras. Neurol Clin 10:331–339PubMed Hoehn MM (1992) The natural history of Parkinson’s disease in the pre-levodopa and post-levodopa eras. Neurol Clin 10:331–339PubMed
2.
Zurück zum Zitat Damasio AR, Lobo-Antunes J, Macedo C (1971) Psychiatric aspects in Parkinsonism treated with l-dopa. J Neurol Neurosurg Psychiatry 34:502–507PubMedCrossRef Damasio AR, Lobo-Antunes J, Macedo C (1971) Psychiatric aspects in Parkinsonism treated with l-dopa. J Neurol Neurosurg Psychiatry 34:502–507PubMedCrossRef
3.
Zurück zum Zitat Evans AH, Lees AJ (2004) Dopamine dysregulation syndrome in Parkinson’s disease. Curr Opin Neurol 17:393–398PubMedCrossRef Evans AH, Lees AJ (2004) Dopamine dysregulation syndrome in Parkinson’s disease. Curr Opin Neurol 17:393–398PubMedCrossRef
4.
Zurück zum Zitat Voon V, Fox SH (2007) Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 64:1089–1096PubMedCrossRef Voon V, Fox SH (2007) Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 64:1089–1096PubMedCrossRef
5.
Zurück zum Zitat Lim SY, Evans AH, Miyasaki JM (2008) Impulse control and related disorders in Parkinson’s disease: review. Ann N Y Acad Sci 1142:85–107PubMedCrossRef Lim SY, Evans AH, Miyasaki JM (2008) Impulse control and related disorders in Parkinson’s disease: review. Ann N Y Acad Sci 1142:85–107PubMedCrossRef
6.
Zurück zum Zitat Pontone G, Williams JR, Bassett SS, Marsh L (2006) Clinical features associated with impulse control disorders in Parkinson disease. Neurology 67:1258–1261PubMedCrossRef Pontone G, Williams JR, Bassett SS, Marsh L (2006) Clinical features associated with impulse control disorders in Parkinson disease. Neurology 67:1258–1261PubMedCrossRef
7.
Zurück zum Zitat Weintraub D, Koester J, Potenza MN et al (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589–595PubMedCrossRef Weintraub D, Koester J, Potenza MN et al (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589–595PubMedCrossRef
8.
Zurück zum Zitat Voon V, Sohr M, Lang AE et al (2011) Impulse control disorders in Parkinson disease: a multicenter case–control study. Ann Neurol 69:986–996PubMedCrossRef Voon V, Sohr M, Lang AE et al (2011) Impulse control disorders in Parkinson disease: a multicenter case–control study. Ann Neurol 69:986–996PubMedCrossRef
9.
Zurück zum Zitat Weintraub D, Siderowf AD, Potenza MN et al (2006) Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 63:969–973PubMedCrossRef Weintraub D, Siderowf AD, Potenza MN et al (2006) Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 63:969–973PubMedCrossRef
10.
Zurück zum Zitat Weintraub D, Hoops S, Shea JA et al (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease. Mov Disord 24:1461–1467PubMedCrossRef Weintraub D, Hoops S, Shea JA et al (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease. Mov Disord 24:1461–1467PubMedCrossRef
11.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef
12.
Zurück zum Zitat Herzog J, Volkmann J, Krack P et al (2003) Two-year follow-up of subthalamic deep brain stimulation in Parkinson’s disease. Mov Disord 18:1332–1337PubMedCrossRef Herzog J, Volkmann J, Krack P et al (2003) Two-year follow-up of subthalamic deep brain stimulation in Parkinson’s disease. Mov Disord 18:1332–1337PubMedCrossRef
13.
Zurück zum Zitat Lee JY, Kim JM, Kim JW, Cho J, Lee WY, Kim HJ, Jeon BS (2010) Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord 16(3):202–207PubMedCrossRef Lee JY, Kim JM, Kim JW, Cho J, Lee WY, Kim HJ, Jeon BS (2010) Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord 16(3):202–207PubMedCrossRef
14.
Zurück zum Zitat Goetz CG, Poewe W, Rascol O, Sampaio C (2005) Evidence-based medical review update: pharmacological and surgical treatments of Parkinson’s disease: 2001 to 2004. Mov Disord 20:523–539PubMedCrossRef Goetz CG, Poewe W, Rascol O, Sampaio C (2005) Evidence-based medical review update: pharmacological and surgical treatments of Parkinson’s disease: 2001 to 2004. Mov Disord 20:523–539PubMedCrossRef
15.
Zurück zum Zitat Voon V, Hassan K, Zurowski M et al (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67:1254–1257PubMedCrossRef Voon V, Hassan K, Zurowski M et al (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67:1254–1257PubMedCrossRef
16.
Zurück zum Zitat Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F (2006) Prevalence of pathological gambling in patients with Parkinson’s disease. Mov Disord 21:2068–2072PubMedCrossRef Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F (2006) Prevalence of pathological gambling in patients with Parkinson’s disease. Mov Disord 21:2068–2072PubMedCrossRef
17.
Zurück zum Zitat Antonini A, Siri C, Santangelo G et al (2011) Impulsivity and compulsivity in drug naive patients with Parkinson’s disease. Mov Disord 26:464–468PubMedCrossRef Antonini A, Siri C, Santangelo G et al (2011) Impulsivity and compulsivity in drug naive patients with Parkinson’s disease. Mov Disord 26:464–468PubMedCrossRef
18.
Zurück zum Zitat Christenson GA, Faber RJ, de Zwaan M et al (1994) Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry 55:5–11PubMed Christenson GA, Faber RJ, de Zwaan M et al (1994) Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry 55:5–11PubMed
19.
Zurück zum Zitat O’Sullivan SS, Djamshidian A, Ahmed Z et al (2010) Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy. Mov Disord 25:638–642PubMedCrossRef O’Sullivan SS, Djamshidian A, Ahmed Z et al (2010) Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy. Mov Disord 25:638–642PubMedCrossRef
20.
Zurück zum Zitat Miyasaki JM, Al Hassan K, Lang AE, Voon V (2007) Punding prevalence in Parkinson’s disease. Mov Disord 22:1179–1181PubMedCrossRef Miyasaki JM, Al Hassan K, Lang AE, Voon V (2007) Punding prevalence in Parkinson’s disease. Mov Disord 22:1179–1181PubMedCrossRef
21.
Zurück zum Zitat Evans AH, Katzenschlager R, Paviour D et al (2004) Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397–405PubMedCrossRef Evans AH, Katzenschlager R, Paviour D et al (2004) Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397–405PubMedCrossRef
22.
Zurück zum Zitat Lawrence AJ, Blackwell AD, Barker RA et al (2007) Predictors of punding in Parkinson’s disease: results from a questionnaire survey. Mov Disord 22:2339–2345PubMedCrossRef Lawrence AJ, Blackwell AD, Barker RA et al (2007) Predictors of punding in Parkinson’s disease: results from a questionnaire survey. Mov Disord 22:2339–2345PubMedCrossRef
23.
Zurück zum Zitat Wolters E, van der Werf YD, van den Heuvel OA (2008) Parkinson’s disease-related disorders in the impulsive-compulsive spectrum. J Neurol 255(Suppl 5):48–56PubMedCrossRef Wolters E, van der Werf YD, van den Heuvel OA (2008) Parkinson’s disease-related disorders in the impulsive-compulsive spectrum. J Neurol 255(Suppl 5):48–56PubMedCrossRef
24.
Zurück zum Zitat Groenewegen HJ, Berendse HW, Wolters JG, Lohman AH (1990) The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: Evidence for a parallel organization. Prog Brain Res 85:95–116 (discussion 116–118)PubMedCrossRef Groenewegen HJ, Berendse HW, Wolters JG, Lohman AH (1990) The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: Evidence for a parallel organization. Prog Brain Res 85:95–116 (discussion 116–118)PubMedCrossRef
25.
Zurück zum Zitat Pezzella FR, Colosimo C, Vanacore N et al (2005) Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson’s disease. Mov Disord 20:77–81PubMedCrossRef Pezzella FR, Colosimo C, Vanacore N et al (2005) Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson’s disease. Mov Disord 20:77–81PubMedCrossRef
26.
Zurück zum Zitat Giovannoni G, O’Sullivan JD, Turner K, Manson AJ, Lees AJ (2000) Hedonistic homeostatic dysregulation in patients with Parkinson’s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423–428PubMedCrossRef Giovannoni G, O’Sullivan JD, Turner K, Manson AJ, Lees AJ (2000) Hedonistic homeostatic dysregulation in patients with Parkinson’s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423–428PubMedCrossRef
27.
Zurück zum Zitat Lim SY, Tan ZK, Ngam PI et al (2011) Impulsive-compulsive behaviors are common in Asian Parkinson’s disease patients: assessment using the quip. Parkinsonism Relat Disord 17:761–764PubMedCrossRef Lim SY, Tan ZK, Ngam PI et al (2011) Impulsive-compulsive behaviors are common in Asian Parkinson’s disease patients: assessment using the quip. Parkinsonism Relat Disord 17:761–764PubMedCrossRef
28.
29.
Zurück zum Zitat Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162:1403–1413PubMedCrossRef Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162:1403–1413PubMedCrossRef
30.
Zurück zum Zitat O’Sullivan SS, Evans AH, Lees AJ (2009) Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS drugs 23:157–170PubMedCrossRef O’Sullivan SS, Evans AH, Lees AJ (2009) Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS drugs 23:157–170PubMedCrossRef
Metadaten
Titel
Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson’s disease
verfasst von
Juyeon Kim
Mijin Kim
Do Young Kwon
Woo-Keun Seo
Ji Hyun Kim
Jong Sam Baik
Seong-Beom Koh
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 2/2013
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6645-9

Weitere Artikel der Ausgabe 2/2013

Journal of Neurology 2/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.